» Articles » PMID: 16828847

The Value of Preoperative Platelet Count in the Prediction of Cervical Involvement and Poor Prognostic Variables in Patients with Endometrial Carcinoma

Overview
Journal Gynecol Oncol
Date 2006 Jul 11
PMID 16828847
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective(s): To evaluate the relationship between preoperative platelet counts and prognostic factors extensively, among endometrial cancer patients, especially with respect to cervical involvement.

Methods: One-hundred fifty-five patients with endometrial carcinoma, who underwent surgery as the initial treatment consisting peritoneal cytology, total abdominal hysterectomy, bilateral salpingo-oophorectomy, systematic pelvic-paraaortic lymphadenectomy, and omentectomy were retrospectively analyzed.

Results: There were no differences with respect to age, histological type (endometrioid vs. non-endometrioid), depth of myometrial invasion, peritoneal cytology, LVSI, and lymphatic metastasis. However, advanced stage (stages III and IV), poorly differentiated tumor grade (grade 3), the presence of cervical and adnexal involvements were associated with significantly higher median preoperative platelet counts. Accepting 325.000/microl platelet count as a threshold value, multivariate analysis revealed cervical involvement (P=0.008; OR=1.84, 95% CI:1.17-2.89) and presence of high grade histology (P=0.014; OR=2.23, 95% CI:1.18-4.23, for grade 3 disease) to be significantly associated with higher platelet count. At a cut-off value of 326.000/microl, 42.3% sensitivity and 82.8% specificity for the prediction of cervical involvement was observed under receiver operator characteristic curve method.

Conclusion(s): Higher preoperative platelet counts, even in conditions with normal range (150.000-400.000/microl), may reflect poor prognostic factors such as cervical involvement and high grade among patients with endometrial carcinoma. Also, the higher platelet count should be taken into consideration for the necessity of radical hysterectomy.

Citing Articles

Serum Total SOD Activity and SOD1/2 Concentrations in Predicting All-Cause Mortality in Lung Cancer Patients.

Skorska K, Placzkowska S, Prescha A, Porebska I, Kosacka M, Pawelczyk K Pharmaceuticals (Basel). 2021; 14(11).

PMID: 34832849 PMC: 8622563. DOI: 10.3390/ph14111067.


Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients.

Zablocka-Slowinska K, Prescha A, Placzkowska S, Porebska I, Kosacka M, Pawelczyk K Nutrients. 2020; 13(1).

PMID: 33375477 PMC: 7824662. DOI: 10.3390/nu13010060.


Platelets and Metastasis: New Implications of an Old Interplay.

Lucotti S, Muschel R Front Oncol. 2020; 10:1350.

PMID: 33042789 PMC: 7530207. DOI: 10.3389/fonc.2020.01350.


Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies.

Ye Q, Wu Z, Xia T, Liu D, Yang Y, Tang H Exp Ther Med. 2019; 19(1):359-366.

PMID: 31853312 PMC: 6909484. DOI: 10.3892/etm.2019.8205.


Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.

Lin C, Kwon H, Rangel Rivera G, Li X, Chung D, Li Z Cancer Epidemiol Biomarkers Prev. 2018; 27(10):1176-1185.

PMID: 30049843 PMC: 6170665. DOI: 10.1158/1055-9965.EPI-18-0408.